Notice of Proposed Sale · 144
Mirum Pharmaceuticals, Inc.
MIRMNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- MIRUM PHARMACEUTICALS, INC.
- Issuer CIK
- 0001759425
- SEC file number
- 001-38981
- Phone
- (650) 667-4085
- Person for whose account securities are to be sold
- JOLANDA MARIE HOWE
- Relationships to issuer
- Officer
- Street
- 989 East Hillsdale Boulevard, Suite 300
- City
- Foster City
- State / country code
- CA
- Postal code
- 94404
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 1,840 | 193,733.60 | 60,981,227 | 08/03/2026 | NASDAQ | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 01/31/2024 | Restricted Stock | Issuer | 1,037 | N | 01/31/2024 | Not Applicable |
| Common | 01/31/2026 | Restricted Stock | Issuer | 803 | N | 01/31/2026 | Not Applicable |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| JOLANDA MARIE HOWE | Common | 07/01/2026 | 2,721 | 326,520.00 |
| JOLANDA MARIE HOWE | Common | 06/17/2026 | 2,594 | 264,458.30 |
Seller — prior-sale row 1, entry 1
- Name
- JOLANDA MARIE HOWE
- Street
- 989 East Hillsdale Boulevard, Suite 300
- City
- Foster City
- State / country code
- CA
- Postal code
- 94404
Seller — prior-sale row 2, entry 1
- Name
- JOLANDA MARIE HOWE
- Street
- 989 East Hillsdale Boulevard, Suite 300
- City
- Foster City
- State / country code
- CA
- Postal code
- 94404
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 08/03/2026
- Signed
- /s/ Jolanda Howe
- Plan adoption dates
- 03/18/2026
Company context
Mirum Pharmaceuticals (NASDAQ: MIRM) is a leading rare disease company with a global footprint of approved products and a broad pipeline of investigational medicines. Purpose-built to bring forward breakthrough medicines for people with overlooked conditions, Mirum focuses on rare liver and rare genetic diseases, where it has built deep expertise and strong connections to patient communities. The company’s commercial portfolio includes LIVMARLI® (maralixibat) for Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC), CHOLBAM® (cholic acid) for bile-acid synthesis disorders, and CTEXLI® (chenodiol) for cerebrotendinous xanthomatosis (CTX).